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Abstract
Background: Prader-Willi syndrome (PWS) is a complex neurodevelopmental disorder, characterized by endocrine
problems and hyperphagia, indicating hypothalamic-pituitary dysfunction. However, few studies have explored the
underlying neurobiology of the hypothalamus and its functional connectivity with other brain regions. Thus, the
aim of this study was to examine the anatomical differences of the hypothalamus, mammillary bodies, and pituitary
gland as well as resting state functional connectivity of the hypothalamus in children with PWS.
Methods: Twenty-seven children with PWS (13 DEL, 14 mUPD) and 28 typically developing children were included.
Manual segmentations by a blinded investigator were performed to determine the volumes of the hypothalamus,
mammillary bodies, and pituitary gland. In addition, brain-wide functional connectivity analysis was performed
using the obtained masks of the hypothalamus.
Results: Children with PWS showed altered resting state functional connectivity between hypothalamus and right
and left lateral occipital complex, compared to healthy controls. In addition, children with PWS had on average a
50% smaller pituitary volume, an irregular shape of the pituitary, and a longer pituitary stalk. Pituitary volume did
not increase in volume during puberty in PWS. No volumetric differences in the hypothalamus and mammillary
bodies were found. In all subjects, the posterior pituitary bright spot was observed.
Conclusions: We report altered functional hypothalamic connectivity with lateral occipital complexes in both
hemispheres, which are implicated in response to food and reward system, and absence of connectivity might
therefore at least partially contribute to the preoccupation with food in PWS.
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Background
Prader-Willi Syndrome (PWS) is a rare and poorly
understood neurodevelopmental disorder that affects 1
in 15,000 live births. PWS is caused by the lack of
expression of the paternally derived genes on chromo-
some 15 at locus q11-q13, due to a deletion (DEL [1],
maternal uniparental disomy (mUPD [2]), unbalanced
translocation, or imprinting center defect [3]). PWS is
characterized by hyperphagia, which is a major concern
for patients with PWS and their caregivers, as it may
lead to obesity, diabetes mellitus, cardiovascular dis-
eases, and, in some cases, death due to stomach
rupture. In addition, patients with PWS suffer from de-
velopmental delays and multiple abnormalities of the
endocrine system, such as short stature, hypogonadism,
delayed and incomplete sexual maturation and infertil-
ity [4, 5], high pain threshold, and abnormalities in
temperature regulation.
Clinical studies have yielded substantial evidence for a
hypothalamus-pituitary axis dysfunction in PWS. Chil-
dren with PWS have low insulin-like growth factor I
(IGF-I) levels prior to treatment with growth hormone
(GH) [6] and might have decreased GH secretion after
provocative testing [7], which contributes to short stat-
ure, increased fat mass, and decreased lean body mass in
PWS. Furthermore, irregular or absent menstrual cycle
in girls, cryptorchidism, and infertility in boys, reduced
secondary sexual characteristics, and decreased bone
density are present in the vast majority of PWS patients,
due to hypogonadism of both central and primary origin
[4, 6]. Both normal and impaired functioning of
hypothalamic-pituitary-adrenal (HPA) and thyroid axes
have been reported, likely due to methodological differ-
ences [8–10].
Neurobiological mechanisms underlying endocrine
problems and particularly hyperphagia in PWS are not
yet fully understood. Smaller anterior pituitary [11],
absent posterior pituitary bright spot [12], and pituitary
empty sella [13] were found in adults with PWS, as well
as a reduction in pituitary height in children with PWS
[14], which might contribute to endocrine dysfunction
in PWS. An increased functional response of the
hypothalamus to food stimuli was found in functional
brain imaging studies in PWS adults [15, 16]. These
results, combined with studies showing structural
abnormalities of the hypothalamus in PWS [17], sug-
gest that a dysfunctional hypothalamus might underlie
abnormal satiety regulation in PWS.
The major shortcoming of task-dependent functional
magnetic resonance imaging (fMRI) studies is that the
research outcome is dependent on the participant’s abil-
ity to understand the instructions of the task, posing a
potential problem in patient populations with cognitive
impairments. An alternate approach to functional brain
activity in patients with PWS is to study resting state
functional connectivity. Functional connectivity of the
brain follows the principle of “what wires together, fires
together” and allows for the quantification of how ana-
tomically separated brain regions co-vary together while
the brain is at rest, thus in the absence of any cognitive
task. However, to date, there are limited studies per-
formed in adults or children with PWS assessing global
hypothalamic connectivity specifically. One study has re-
ported increased connectivity between hypothalamus
and amygdala in untreated children with PWS [18]. In
an obese, but otherwise healthy cohort, both increased
and decreased resting-state connectivities have been
found in multiple brain areas responsible for behavioral
control, reward and motivation [19, 20]. An abnormal
functional response of the hypothalamus to food stimuli
was found, indicating that hypothalamic dysfunction
might underlie hyperphagia in PWS [15]. It is therefore
likely that aberrant functional resting-state connectivity
might underlie abnormal response to food not only in
obese individuals but also in individuals with PWS.
Based on the neuroendocrine symptoms found in
PWS, the primary goal of this study was to investigate
the neurobiology of the hypothalamus, including rest-
ing state functional connectivity and volumetric mea-
sures of the hypothalamus, mammillary bodies (due to
their distinct structure), and the pituitary gland in
children with PWS compared to controls. Given the
evidence of abnormal hypothalamic functioning in the
PWS, we hypothesized that abnormal resting-state
connectivity of the hypothalamus would be present in
children with PWS, particularly with the brain areas
implicated in reward and behavioral regulation. We
also hypothesized that the hypothalamus, together
with the pituitary gland, would be smaller in volume
in children with PWS, compared to healthy controls,
given the abundance of evidence for hypothalamus-
pituitary dysfunction in PWS. In addition, we also
measured the length of the pituitary stalk.
Methods
Participants
Twenty-seven children with PWS and 28 typically
developing children were included. Inclusion criteria
for PWS group were (1) genetically confirmed PWS, (2)
age 6–23 years, and (3) no neurological or psychiatric
history. Inclusion criteria for the healthy control group
were (1) age 6–23 years, and (2) no neurological or
psychiatric history. All children with PWS participated
in the Dutch PWS Cohort Study [21]. The study was
approved by the Medical Ethics Committee of the
Erasmus Medical Center Rotterdam, Rotterdam, The
Netherlands. Written informed consent was obtained in
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all cases from the caregivers and children older than
12 years and informed assent in children younger than
12 years.
MRI acquisition
Children were introduced to a mock scanner before they
underwent the MRI scan. Caregivers were given the op-
tion to stay in the room with the MRI scanner, close to
their child.
All images were acquired on a 3T GE 750 Discovery
MRI scanner (General Electric, Milwaukee, WI, USA),
using a dedicated 8-channel head coil. Following 3-plane
localizing and coil intensity calibration scans, a high-
resolution T1-weighted inversion recovery fast spoiled
gradient recalled (IR FSPGR) sequence was obtained
with the following parameters: TR = 10.3 ms, TE =
4.2 ms, TI = 350 ms, NEX = 1, flip angle = 16°, readout
bandwidth = 20.8 kHz, matrix 256 × 256, imaging accel-
eration factor of 2, and an isotropic resolution of 0.9 ×
0.9 × 0.9 mm3 (duration; 5 min 40 s). Resting-state fMRI
(rs-fMRI) utilized a gradient-echo blood oxygen level
dependent (BOLD) EPI sequence with a TR = 2000 ms,
TE = 30 ms, flip angle = 85°, matrix 64 × 64, and voxel
resolution of 3.6 ×3.6 × 4.0 mm3. The duration of the rs-
fMRI was 160 TRs (5 min 20 s). The children were
asked to keep their eyes closed during the rs-fMRI se-
quence and to think about nothing in particular. All
MRI images were reviewed by a qualified radiologist and
no gross brain abnormalities were identified.
Twenty-two children with PWS and 27 healthy con-
trols had both structural MRI and resting state fMRI
data available, suitable for manual segmentation func-
tional connectivity analysis, respectively.
Data processing
Manual segmentation
All MRI images were coded to ensure investigators’
blindness to subject identification and diagnosis. Manual
segmentation of the hypothalamus, mammillary bodies,
and pituitary gland were performed with the FreeSurfer
5.3 image analysis suite. Tracing was performed slice by
slice (1-mm thick) in coronal, axial, and sagittal orienta-
tions. Thus, the anatomic boundaries were viewed from
different orientations. The hypothalamus segmentation
boundaries used were based on the boundaries used by
Klomp et al. [21] and Lemaire et al. [22]. The anterior
boundary of the hypothalamus was defined by the first
coronal slice after the anterior commissure (AC) and the
posterior boundary by the last slice where the
mammillary bodies were visible. The dorsal boundary
consisted of the AC-PC (posterior commissure) plane in
the transverse section or the hypothalamic sulcus and
ventral border of the lamina terminalis. The lateral
boundaries were determined by the white matter
bundles. The boundaries of the mammillary bodies were
defined anterior by the first coronal slice in which the
mammillary bodies were visible as part of the hypothal-
amus and posterior by the very last slice in which they
were still visible. The floor of the third ventricle and the
cerebral spinal fluid (CSF)-filled suprasellar cistern de-
fined the dorsal and ventral boundaries, respectively.
Laterally the boundaries consisted of the darker gray of
the hypothalamus or the bundle of white matter that
surrounds it.
We measured pituitary volume instead of pituitary
height, as the latter measure only weakly correlates with
pituitary volume [23]. The boundaries of the pituitary
gland were defined anteriorly and ventrally by the
sphenoid sinus, posteriorly by the dorsum sellae, dorsally
by the diaphragma sellae, and laterally by the cavernous
sinuses. The infundibular stalk was excluded from the
segmentations. For each subject, it was assessed whether
the posterior pituitary bright spot (PPBS) was present.
The length of the pituitary stalk was defined and mea-
sured as the distance from the tip of the infundibular
recesses to the junction of the pituitary stalk and the
pituitary gland, along the course of the pituitary stalk.
Resting-state functional connectivity
All rs-fMRI data were preprocessed by the FMRIB’s Dif-
fusion Toolbox (FDT) from the FMRIB’s freely available
Software Library (FSL, http://www.fmrib.ox.ac.uk/fsl).
First, the first four volumes of rs-fMRI scan of each
participant were discarded to allow for T1-
equilibration effects. Each subject’s functional images
were motion-corrected with MCFLIRT, spatially
smoothed with an 8-mm spatial filter (White et al.
2001) and denoised using FSL’s ICA-based X-noiseifier
(FIX) tool [24], regressing out six motion parameters.
Individual hypothalamus masks, obtained from the
manual segmentations, were registered into functional
space using FLIRT, and the individual fMRI time series
within the hypothalamus ROI were extracted. Individ-
ual whole-brain voxel-wise regression analyses were
performed with FSL’s FEAT using the time series
within the hypothalamus as the independent variable,
controlling for the white matter and CSF time series.
The obtained z-transformed individual images were
then registered to the high-resolution structural image,
and both structural and functional images were registered
into standard space using the Montreal Neurological
Institute T1 template (MNI52) using FSL’s FLIRT. We
then generated group mean connectivity maps as well as
tested for group differences (PWS vs. control, DEL vs.
control, mUPD vs. control and DEL vs. mUPD), using
FSL’s randomize permutation-testing tool with 5000 per-
mutations, excluding white matter and CSF voxels, and
threshold-free cluster enhancement (TFCE), accounting
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for age and gender effects and setting p value at <0.05.
The minimal number of voxels for a cluster to be consid-
ered was set at 50. Family-wise error (FWE) was used to
correct for multiple comparisons. Fisher’s z-transformed
partial correlation coefficients were estimated.
Hormones and assays
Blood samples for the assessment of IGF-1, thyroid
stimulating hormone (TSH), T4, free T4 (fT4), T3, and
reverse T3 (rT3) were collected prior to start with GH
treatment, in the morning, after overnight fasting. After
centrifugation, the samples were immediately frozen at –
20 °C until assayed.
Serum IGF-I levels were measured in one central
laboratory using a immunometric technique on an
Advantage Automatic Chemiluminescence System
(Nichols Institute Diagnostics, San Juan Capistrano,
CA). The intraassay coefficient of variation was 4%,
and the interassay coefficient of variation was 6%. Be-
cause of age and sex dependency, IGF-I levels were
transformed into standard deviation scores (SDS) [25].
Plasma levels of rT3 were measured by established
radioimmunoassay procedures, as described previously
[10]. Serum TSH, free T4, T4, and T3 levels were mea-
sured by Vitros Eci technology (Ortho-Clinical Diagnos-
tics, Amersham, UK) [10]. The within-assay coefficient
of variation (CV) was 3–7% and the between-assay CV
5–10%. Thyroid hormone SDSs were calculated with
data from a control group comprising 500 healthy Dutch
children (aged 1.4–18 years) from the Rotterdam region,
The Netherlands, participating in a study to assess
reference values.
The fasting blood samples were taken for the analysis
of maximal adrenocorticotropic hormone (ACTH)
levels after overnight single-dose metyrapone test,
after start of treatment with GH (for detailed descrip-
tion, see [8]). Plasma ACTH levels were measured
with an immunoradiometric assay (Bio-International,
Gif-sur-Yvette, France) with a minimal detection level
of 1.1 pmol/liter. Glucose levels were measured with
the Hitachi 917 (Hitachi Device Development Center,
Tokyo, Japan), detecting glucose levels between 0 and
42 mmol/liter.
Statistical analyses of volumetric data
Intrarater reliability of the volume measurements,
assessed by intraclass correlation coefficient (ICC) in the
five brains was as follows: the hypothalamus (ICC =
0.97), mammillary bodies (ICC = 0.73), and pituitary gland
(ICC = 0.99).
Interrater reliability of the volume measurements,
assessed by intraclass correlation coefficient (ICC), for
five randomly selected patients by two raters (AL and
SD) who were both blinded to subject identification and
diagnosis was as follows: the hypothalamus (ICC = 0.93),
mammillary bodies (ICC = 0.76), and pituitary gland
(ICC = 0.99).
Volumes of the hypothalamus, mammillary bodies, and
pituitary gland and pituitary stalk length were exported to
SPSS (version 21, IBM Corporation, Armonk, NY, USA)
for statistical analyses. Groups were compared using a
nonparametric Mann-Whitney or Kruskal-Wallis analysis
of variance test and a chi-square, where appropriate. For
significant group effects only, post hoc Mann-Whitney
tests were performed for pairwise comparisons with a
Bonferroni correction of p = .05/3 (DEL, mUPD, and con-
trol). For interaction effects between pituitary volume and
age, nonparametric Quade’s rank analysis of covariance
was performed.
Results
Demographic data and clinical data of the patients are pre-
sented in Table 1. No significant differences were found in
age and gender distribution between both groups.
Hypothalamic functional connectivity
Hypothalamic connectivity maps for PWS and controls
are presented in Fig. 1. After accounting for multiple
testing, children with PWS, compared to healthy con-
trols had increased connectivity between the hypothal-
amus and two small clusters in both the right
(104 voxels, p < .05) and left (126 voxels, p < .05) lateral
occipital complex (LOC) (Fig. 2). Fisher’s z-transformed
partial correlations between the hypothalamus and lat-
eral occipital complexes were negative in controls and
close to 0 in PWS (Fig. 2). No other brain areas were
found to have altered functional connectivity, either in-
creased or decreased, with the hypothalamus. No signifi-
cant differences were found between genetic subtypes,
and no trends were detected either.
Volumes of the hypothalamus and mammillary bodies
There were no significant differences in volume of the
hypothalamus or mammillary bodies between children
with PWS and healthy controls (Table 2). During the
manual tracing, no anatomical aberrations were ob-
served, the hypothalamus and mammillary bodies had
normal appearance in all subjects.
Volume of pituitary gland
A posterior pituitary bright spot (PPBS) was identified in
all subjects (Fig. 3) The pituitary gland was smaller in
the PWS children and had a flattened, boat-like shape,
in combination with a longer pituitary stalk. The
pituitary stalk was intact in all subjects. Children with PWS
had a significantly a smaller pituitary volume (p < .001) and
a significantly longer pituitary stalk (p < .05) compared
to the healthy controls. Pituitary volume correlated
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strongly with age in both groups (rho = .40, p < .01
(combined); rho = .69, p < .0001 (control); rho = .46, p
< .05 (PWS)). It did not increase in volume with age
in PWS, in contrast with healthy controls (p < .0001).
Post hoc analyses revealed no significant differences
between the DEL and mUPD subtypes (Fig. 4).
Pituitary gland volume correlations with baseline
hormonal levels
Pituitary gland volume correlated positively with base-
line TSH (p < .05) and showed a trend towards a positive
correlation with baseline IGF-I SDS levels, but not with
fT4 and ACTH (Table 1).
Fig. 1 Hypothalamic connectivity maps in individuals with PWS and healthy controls. Hypothalamic connectivity maps: blue, healthy controls;
red, PWS; green, overlapping connectivity. Connectivity maps were processed with TFCE and thresholded at FWE-corrected p < .05
Table 1 Demographic and clinical data of the participants
PWS Control p
value
Correlations with pituitary gland (in PWS only)
DEL mUPD rho p value
Sample size (n) 14 13 28
Age (years) 13.7 (3.5) 12.5 (5.1) 13.0 (3.1) .93
Age range (years) 8.1–21.4 6.0–23.3 7.1–18.0
Male (n) 6 3 11
Female (n) 8 10 17
IGF-I SDS −2.0 (1.5) −3.2 (1.9) .04 .31 .14
TSH (mU/l) 2.2 (1.1) 2.4 (1.0) .62 .51 .016
Free T4 (pmol/l) 16.6 (2.5) 16.2 (2.3) .43 −.22 .32
T3 (nmol/l) 2.6 (.7) 3.2 (1.9) .25 .11 .64
Reverse T3 (nmol/l) .37 (0.6) .38 (1.0) .97 −.49 .03
ACTH (pmol/l) 30.2 (20.1) 30.3 (17.6) 1.0 −.36 .23
Data expressed as mean (SD) or number. No significant differences were found in either age or gender distribution between the groups
DEL deletion, mUPD maternal uniparental disomy, PWS Prader-Willi syndrome, SD standard deviation
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Discussion
Our study investigated global functional resting-state
connectivity as well as volume of the hypothalamus and
pituitary gland in children with PWS. Children with
PWS had no resting-state functional connectivity be-
tween the hypothalamus and lateral occipital complex
(LOC) in both hemispheres, compared to negative
correlation found in healthy controls. Hypothalamic
volume was similar in both PWS and controls. In
addition, children with PWS had a much smaller pituit-
ary gland (on average 50% smaller), together with a
longer, albeit uninterrupted pituitary stalk. PPBS was
present in all cases, both in patients and controls.
The lateral occipital complex (LOC) is involved in vis-
ual processing, object recognition [26], and tracking the
caloric value of foods [27]. In a recently conducted
meta-analysis analyzing functional MRI studies that
addressed processing of food vs. nonfood pictures, LOC
appeared to be one of the most robust brain areas
associated with processing food related stimuli, found in
multiple studies, along with the orbitofrontal cortex and
insula [28]. LOC is an important hub for processing of
visual food information as it is functionally connected to
the satiety center (hypothalamus), reward system (nu-
cleus accumbens), and cognitive control center (orbito-
frontal cortex) [29]. Visual network, including LOC, is
Table 2 Hypothalamus and pituitary gland volumes in children with PWS
PWS Control
mUPD DEL
Mean SD Mean SD Mean SD p valuea
Hypothalamus 5395.0 1109.5 5542.2 1101.6 5657.3 1349.3 .82
Mammillary bodies 922.8 177.5 788.8 85.7 970.1 168.8 .33
Pituitary gland 1279.4 501.4 1267.3 394.0 2674.6 1057.8 <.0001
Posterior pituitary bright spot 13/13 14/14 28/28
Pituitary stalk length (mm) 7.9 1.9 7.07 2.5 5.6 2.0 .041
Interrupted stalk 0/13 0/14 0/28
Data expressed as mean (SD) or number (mm3) unless indicated otherwise. No significant differences were found in either age or gender distribution between
the groups
DEL deletion, mUPD maternal uniparental disomy, PWS Prader-Willi syndrome, SD standard deviation
aPWS vs. control
Fig. 2 Altered functional connectivity between the hypothalamus and lateral occipital cortex in PWS. The coordinates, size, corresponding partial
correlation coefficients, and p values are indicated underneath in Fig. 2
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also modulated by the limbic system, which results in
the enhanced visual processing of emotionally relevant
stimuli, including food [30]. It is therefore very intri-
guing that we found the absence of resting-state func-
tional connectivity between LOC and the hypothalamus
in individuals with PWS, which could potentially lead to
abnormal processing of food cues and integration of sa-
tiety responses and thus be associated with the preoccu-
pation with food seen in PWS patients. Interestingly, we
did not find involvement of prefrontal cortex, in contrast
to previous studies, which suggested an impairment in
cognitive control mechanisms [31].
Although our findings may suggest that altered hypothal-
amic connectivity in PWS may relate to a preoccupation
with food, thus contributing to hyperphagia, the auto-
nomic symptoms of PWS of strictly hypothalamic ori-
gin (such as high pain threshold, inability to develop
fever in case of illness), and their neurocorrelates re-
main to be clarified. Hypothalamus connectivity maps
in our study largely resemble those obtained in another
study, minor differences between the maps can be ex-
plained by methodogical aspects such as size of a
chosen seed [29]. High-resolution microscopic studies
or animal models might be necessary to further explain
the hypothalamic impairment in PWS.
Surprisingly, no significant differences were found in
the volume of the hypothalamus or mammillary bodies
between PWS and healthy controls. Post mortem PWS
studies showed that the size of paraventricular nucleus
(PVN) and the number of oxytocin secreting neurons
within PVN were reduced in patients with PWS [17]. As
PVN is located within the medial part of the hypothal-
amus, it is possible that structural abnormalities, if any,
are restricted to the medial hypothalamus only and are
not observable when quantifying the entire hypothalamic
volume. Due to lack of visible boundaries on the MRI
images between hypothalamic nuclei, it is not possible
with the current resolution found in clinical MRI ma-
chines to study these areas separately. It is important to
note that post mortem studies were based on adults with
PWS; therefore, we cannot exclude that some changes in
the volume of the hypothalamus might have occurred
later in life or after death.
The pituitary gland was significantly smaller in individ-
uals with PWS and often had a flat shape, resembling a
boat with a cavity-like opening encircling the region
where the pituitary stalk roots itself into the gland, ra-
ther than a round pea-shaped structure as one would
expect. We found PPBS to be present in all cases, both
PWS and controls, in contrast to another study that
Fig. 3 Pituitary gland abnormalities in PWS. Left, patient with PWS; right, healthy control; both are of the same age and gender. Note the present
posterior bright spot in both the left and right images, within the red circle. The contours of the pituitary gland are marked with green line.
Horizontal blue lines indicate the approximate location of the superior pituitary border and infundibular recess for the measurement of the
pituitary stalk length. Please note the boat-like cavity around the place where pituitary stalk roots itself into the gland and a long pituitary stalk
in PWS
Fig. 4 Pituitary volume and age in children with PWS and healthy
controls. Pituitary volume was significantly different in both groups
(p < .0001), with a significant pituitary volume by age interaction
between PWS and controls (p < .0001)
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reported the absence of the PPBS in patients with PWS
[32]. Although our investigators were blinded for the
diagnosis of the subjects, often the differences in the
shape of the pituitary gland and the length of the stalk
were so striking that they divided the study group in two
subgroups—those with normally looking pituitary and a
short stalk and those with a small pituitary and long
pituitary stalk.
The volume of pituitary gland correlated strongly with
age in both groups, although it did not show the same
age-related increase during the pubertal period seen in
the older adolescents and young adults with PWS. We
did not assess pubertal stage in healthy controls as our
study was not designed to address these issues, so we
could not perform statistical analyses to support this ob-
servation. Based on our results, we can only speculate
that in prepubertal children with PWS, the developmen-
tal differences seen in the pituitary gland may parallel
the endocrine differences in children with PWS. Thus,
one possibility is that the activation of the pituitary
gland during puberty falls behind in the PWS children,
resulting in inability to function optimally during pu-
berty, which contributes to delayed growth and sexual
maturation in individuals with PWS.
The lower pituitary volumes in the PWS group corre-
lated with the lower TSH levels and showed a trend to-
wards significance with the lower baseline IGF-I SDS
levels, but not with the other baseline endocrine parame-
ters. Children with PWS have reduced IGF-I levels and
might also have low thyroid functioning [10, 25]. In
addition, children with PWS had a significantly longer
pituitary stalk compared to healthy controls. To our
knowledge, a longer pituitary stalk has not been previously
described. During the pituitary development, pituitary
stalk forms from the neuroderm, together with posterior
pituitary, and consists of axons that carry vasopressin and
oxytocin and the releasing hormones from the medial
hypothalamus to the pituitary gland [17]. It might be that
connectivity between the hypothalamus and pituitary is
adversely affected; however, due to susceptibility artifacts,
the white matter connectivity between the pituitary and
hypothalamus could not be measured.
There are several limitations to our study. First, the
sample size was relatively small, although respectable
for a study of PWS. A larger sample size would allow
us to better evaluate differences between the genetic
subtypes as well as the association with pubertal mea-
sures. Second, the cross-sectional design does not
allow us to evaluate developmental trajectories in chil-
dren with PWS compared to controls. Finally, at the
time of the study, all children with PWS received GH
treatment (1 mg/m2 per day); therefore, the children
with PWS may have less abnormalities compared to
untreated patients.
Conclusions
Children with PWS showed altered resting state func-
tional connectivity between the hypothalamus and
LOC in both hemispheres compared to healthy con-
trols. Given the involvement of LOC in the visual
processing of food stimuli, the altered functional con-
nectivity between the hypothalamus and LOC might at
least partially underlie the preoccupation with food in
PWS. No volumetric differences in the hypothalamus
and mammillary bodies were found between PWS and
controls. In contrast, children with PWS had on aver-
age a 50% smaller pituitary volume, an irregular shape
of the pituitary, and a longer pituitary stalk. In all
subjects, a posterior pituitary bright spot was observed.
No significant differences were found between the DEL
and mUPD subtypes in the morphology or connectivity
of the hypothalamus.
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